Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT34-CMI: CLBS14 for Refractory Chronic Myocardial Ischemia
NCT00300053Phase 2Completed
- Sponsor
- Lisata Therapeutics
- Start
- Apr 2006
- Primary completion
- Mar 2008
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous CD34+ cells in chronic myocardial ischemia (CMI), sponsored by Lisata Therapeutics. Started Apr 2006; status: completed.
02
Drugs
autologous CD34+ cells
03
Conditions
chronic myocardial ischemia (CMI)
Beyond the preview
Go deeper on NCT00300053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300053.